Advanced in Migraine with Brainstem Aura

Dr. Salil U. Nadkarni

Family Medicine
1015 N Kings Rd, Suite 108, 
West Hollywood, CA 
Advanced in Migraine with Brainstem Aura
1015 N Kings Rd, Suite 108, 
West Hollywood, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Salil Nadkarni is a primary care provider, practicing in Family Medicine in West Hollywood, California. Dr. Nadkarni is rated as an Advanced provider by MediFind in the treatment of Migraine with Brainstem Aura. His top areas of expertise are Familial Hemiplegic Migraine, Migraine with Brainstem Aura, and Migraine.

His clinical research consists of participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 3 clinical trials in the study of Migraine with Brainstem Aura.

Specialties
Family Medicine
Licenses
Adult Medicine in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

1015 N Kings Rd, Suite 108, West Hollywood, CA 90069

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test
Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test
Enrollment Status: Completed
Publish Date: January 11, 2021
Intervention Type: Device
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: August 19, 2020
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 7 Less Clinical Trials
Similar Doctors
Advanced in Migraine with Brainstem Aura
Dr. Edward J. Banman
Family Medicine
Advanced in Migraine with Brainstem Aura
Dr. Edward J. Banman
Family Medicine

Primary Medical Group Of Ventura County Inc

2772 Johnson Dr, Suite 200, 
Ventura, CA 
 (48.4 miles away)
805-642-1430
Languages Spoken:
English
See accepted insurances

Edward Banman is a primary care provider, practicing in Family Medicine in Ventura, California. Dr. Banman is rated as an Advanced provider by MediFind in the treatment of Migraine with Brainstem Aura. His top areas of expertise are Tietz Syndrome, Costochondritis, Familial Hypertension, and Hypertension.

Advanced in Migraine with Brainstem Aura
Dr. Nahla H. Salem
Family Medicine
Advanced in Migraine with Brainstem Aura
Dr. Nahla H. Salem
Family Medicine
8101 Newman Avenue, Suite B, 
Huntington Beach, CA 
 (32.8 miles away)
714-847-3030
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nahla Salem is a primary care provider, practicing in Family Medicine in Huntington Beach, California. Dr. Salem is rated as a Distinguished provider by MediFind in the treatment of Migraine with Brainstem Aura. Her top areas of expertise are Acute Cystitis, Otitis, Cellulitis, and Urinary Tract Infection in Children. Dr. Salem is currently accepting new patients.

Experienced in Migraine with Brainstem Aura
Dr. Ana C. Fajardo
Family Medicine
Experienced in Migraine with Brainstem Aura
Dr. Ana C. Fajardo
Family Medicine
845 East Chapman Avenue, 
Orange, CA 
 (36.7 miles away)
714-997-2899
Languages Spoken:
English
See accepted insurances

Ana Fajardo is a primary care provider, practicing in Family Medicine in Orange, California. Dr. Fajardo is rated as an Advanced provider by MediFind in the treatment of Migraine with Brainstem Aura. Her top areas of expertise are Autoerythrocyte Sensitivity, Purpura, Gardner-Diamond Syndrome, and Cirrhosis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nadkarni's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile